Furthermore, the meta-analysis found that cerebrospinal fluid IL-17 levels were significantly associated with GBS (Hedges g, 1.882; 95% CI, 0.104-3.661; <i>p</i> = 0.038). The gene discussed is IL17A; the disease is Guillain-Barre syndrome.